Masonic Cancer Center, University of Minnesota
D

Drug Targets and Synthetic Vulnerabilities in Sarcoma: Our Experience in NF1

By Masonic Cancer Center, University of Minnesota FEATURING David Largaespada
By Masonic Cancer Center, University of Minnesota FEATURING David Largaespada
67 views
December 12, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
13:04
Douglas Beall

Spinal Tumor Ablation and Vertebral Augmentation for Treatment of Pa…

27:04
Fengting Yan

Cancer Screening Molecular Tools

06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
06:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of C…

Feat. A. Medford
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

41:07
Yale Cancer Center

Understanding Your Cancer Risk and Options for Cancer Prevention

Feat. V. Giri, T. Shroff
23:00
Total Health

ctDNA and MRD: Who, What, and Then What?

Feat. A. Parikh
22:07
Total Health

2024 Update in Sarcomas

Feat. D. Portnoy
19:05
International Congress on Cancer Metastasis

Could We Cure Metastatic Breast Cancer?

Feat. L. Pusztai
21:23
2023 Evolution Conference

Comprehensive Genomic Profiling: Why Aren't We Doing It?

Feat. J. Meisel
67:04
European School of Oncology

Basic Principles of Tumor Immunology

Feat. M. van den Broek
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
10:41
Francesco Massari

Treatment Approaches in Bone Metastases Pain Management

20:31
Total Health

Diagnostics: Genomics for Treatment Planning of Breast Cancer

Feat. R. L. Mahtani
18:46
OncoAlert

Systemic Therapies for Uterine Leiomyosarcoma

Feat. I. Ray-Coquard
19:40
Warren Chow

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

09:48
ecancer

ESMO 2022 on the PATHFINDER Study: A New Era of Early Cancer Detecti…

Feat. D. Schrag
11:17
Jack William Jennings

NCCN Guidelines on Utilizing Radio-Frequency Ablation to Treat Metas…

15:45
i3 Health

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

Feat. S. Patel, B. Ruben, K. Polson